Sanjay Chanda
Corporate Officer/Principal presso AN2 THERAPEUTICS, INC.
Patrimonio netto: 56 188 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Sanjay Chanda
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Unknown | 18 | ||
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Cortene, Inc.
 Cortene, Inc. BiotechnologyHealth Technology Cortene, Inc. develops interventional treatment for myalgic encephalomyelitis. The company is headquartered in Burlingame, CA.
1
| Holding Company | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sanjay Chanda tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | President Public Communications Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal General Counsel | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| SENOMYX INC. | Food: Specialty/Candy | Chairman Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chief Executive Officer Chairman | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Rho Capital Partners, Inc.
 Rho Capital Partners, Inc. Investment ManagersFinance Rho Capital Partners, Inc. (Rho Capital Partners) is a venture capital firm founded in 1981 by Joshua Ruch. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree | |
| VIATRIS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| NEPHROGENEX INC | Medical Distributors | Director/Board Member Chairman | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chairman | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Mc2 Therapeutics AS
 Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Mc2 Therapeutics is a Danish commercial stage biotech company that focuses on developing novel treatment paradigms for immune-mediated and inflammatory diseases. Mc2 Therapeutics is based in Denmark, specifically in Hørsholm, and has subsidiaries in the United Kingdom. The company is privately held and is developing a new standard of topical therapies for chronic inflammatory conditions using PAD™ technology. The company aims to release the full potential of novel topical drugs for the benefit of patients, physicians, payers, and societies. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| VAXART, INC. | Biotechnology | Chairman Director/Board Member | |
| Kelley School of Business | College/University | Undergraduate Degree Masters Business Admin | |
| BETTER THERAPEUTICS, INC. | Founder Director/Board Member | ||
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Part of Better Therapeutics, Inc., Better Therapeutics LLC is a company that focuses on clinical development and creating habits that heal to reduce the need for other treatments. The company is based in San Francisco, CA. The company is pioneers in the field of prescription digital therapeutics for treating a range of cardiometabolic diseases. The company was founded by David P. Perry and Kevin J. Appelbaum. Kevin J. Appelbaum has been the CEO of the company since 2015. Better Therapeutics was acquired by Mountain Crest Acquisition Corp. II on October 28, 2021 for $164.55 million. | Medical Specialties | Founder Director/Board Member | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Reactive Biosciences, Inc.
 Reactive Biosciences, Inc. BiotechnologyHealth Technology Reactive Biosciences Inc. engages in the design and developemnt of novel solutions targeting needs in crop protection, animal health and human health. It specializes in chemistry, research, and biotechnology. The company was founded by Stephen J. Benkovic, Gerald R. Fink, Lucy Shapiro, Paul R. Schimmel and C. Tony Liu in 2015 and is headquartered in Durham, NC. | Biotechnology | Founder Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 42 |
| Svizzera | 3 |
| Regno Unito | 3 |
| Australia | 2 |
| Danimarca | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 267 |
| Corporate Officer/Principal | 124 |
| Independent Dir/Board Member | 79 |
| Chairman | 49 |
| Chief Executive Officer | 46 |
Contatti più connessi
| Insiders | |
|---|---|
| Mark Leschly | 36 |
| Julie Cherrington | 32 |
| Anders Hove | 31 |
| Joseph Zakrzewski | 30 |
| Paul Berns | 28 |
| Carole Nüchterlein | 26 |
| Wendell Wierenga | 23 |
| Douglas Giordano | 22 |
| Patricia Martin | 21 |
| Robert Karr | 21 |
| Robin Readnour | 20 |
| Keith Leonard | 20 |
| Lucy Shapiro | 18 |
| Richard Markham | 17 |
| Maggie FitzPatrick | 16 |
- Borsa valori
- Insiders
- Sanjay Chanda
- Connessioni Società
